In her leadership role at MyPART, Abby leads a group of scientists, patients, family members, advocates, and healthcare providers working to help find treatments for childhood, teen and young adult solid rare tumors. Her research background is in the areas of molecular tumor virology and gene therapy.
Abby has been with the NCI for 22 years as executive secretary of the President’s Cancer Panel, special assistant to the director of the NCI Center for Cancer Research Rare Tumors Initiative, executive secretary of the NCI Board of Scientific Counselors, Subcommittee 1 – Clinical Sciences and Epidemiology, and as acting chief and chief of the NCI Institute Review Office. Prior to NCI, she was a program director for the Department of Veterans Affairs Medical Research Service in Washington, DC. and a scientist for Pro-Virus, Inc. (now Wellstat Biologics).
Alliance for Rare Cancers I Jedi Rare Cancer Foundation
P.O. Box 683501, Park City, Utah 84068
The Alliance for Rare Cancers is a fiscally sponsored program of the Jedi Rare Cancer Foundation, a 501(c)(3) nonprofit organization, accepting tax-deductible donations from individuals, corporations, family-advised funds, and foundations. Federal Tax ID 86-2610819. All donations are tax deductible as allowed by law.I
DISCLAIMER: THIS WEBSITE DOES NOT PROVIDE MEDICAL ADVICE The information, including but not limited to, text, graphics, images and other material contained on this website are for informational purposes only. No material on this site is intended to be a substitute for professional medical advice, diagnosis or treatment. Always seek the advice of your physician or other qualified health care provider with any questions you may have regarding a medical condition or treatment and before undertaking a new health care regimen, and never disregard professional medical advice or delay in seeking it because of something you have read on this website.